STOCK TITAN

Yeiseok Kim appointed COO at OSR Holdings (NASDAQ: OSRH)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

OSR Holdings, Inc. appointed Yeiseok Kim as Chief Operating Officer, effective April 16, 2026. The Board approved his appointment on March 26, 2026, and an amended employment agreement provides for increased annual compensation.

Kim, age 36, previously served as a Senior Analyst at OSR Holdings Co., Ltd. from 2020 to 2025, supporting cross-border healthcare investments and pharmaceutical licensing. He holds a BA in Environmental Science from Seoul National University and an MS in Medicine from Jeonbuk National University, along with a Korean medical license obtained in 2019.

The company notes there are no special arrangements or understandings behind his appointment, no family relationships with directors or executives, and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Effective date of COO appointment April 16, 2026 Date Yeiseok Kim’s role as Chief Operating Officer becomes effective
Board approval date March 26, 2026 Date the Board of Directors approved Yeiseok Kim’s appointment
Yeiseok Kim age 36 Stated age of the newly appointed Chief Operating Officer
Senior Analyst tenure 2020–2025 Period Kim served as Senior Analyst at OSR Holdings Co., Ltd.
Korean medical license year 2019 Year Yeiseok Kim obtained his Korean medical license
Emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02 – Departure of Directors or Certain Officers; Election of Directors"
Chief Operating Officer financial
"approved the appointment of Yeiseok Kim as Chief Operating Officer of the Company"
A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.
Regulation S-K regulatory
"any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K"
A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.
employment agreement financial
"entered into an amended employment agreement with Mr. Kim"
false 0001840425 0001840425 2026-04-16 2026-04-16 0001840425 OSRH:CommonStockParValue0.0001PerShareMember 2026-04-16 2026-04-16 0001840425 OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-04-16 2026-04-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 16, 2026

 

OSR HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41390   84-5052822
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

10900 NE 4th Street, Suite 2300, Bellevue, WA 98004

(Address of principal executive offices, including zip code)

 

(425) 635-7700
(Registrant’s telephone number, including area code)

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001 per share   OSRH   The Nasdaq Stock Market LLC
Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share   OSRHW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On March 26, 2026, the Board of Directors (the “Board”) of OSR Holdings, Inc. (the “Company”) approved the appointment of Yeiseok Kim as Chief Operating Officer of the Company, effective April 16, 2026.

 

Mr. Kim, age 36, most recently served as a Senior Analyst at OSR Holdings Co., Ltd., a subsidiary of the Company, from 2020 to 2025, where he supported the Company and its subsidiaries’ cross-border healthcare investments and pharmaceutical licensing activities. Prior to joining the Company, Mr. Kim obtained his Korean medical license in 2019. Mr. Kim received a BA in Environmental Science from Seoul National University in 2013 and an MS in Medicine from the Graduate School of Medicine at Jeonbuk National University in 2019. Mr. Kim is well qualified as Chief Operating Officer of the Company because of his medical expertise and experience in cross-border healthcare investment and pharmaceutical licensing.

 

In connection with his appointment as Chief Operating Officer, OSR Holdings Co., Ltd. entered into an amended employment agreement with Mr. Kim, pursuant to which he serves as Chief Operating Officer of the Company, which reflects an increase in his annual compensation. Under such arrangement, Mr. Kim will receive: 

 

  A base salary of KRW 240,000,000 per year;

 

  Participation in Equity-based Compensation Plan of the Company, as determined at the discretion of the Company’s Compensation Committee; and

 

  Other customary benefits available to executive officers of the Company.

 

There are no arrangements or understandings between Mr. Kim and any other person pursuant to which he was appointed as Chief Operating Officer. There are no family relationships between Mr. Kim and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

OSR HOLDINGS, INC.

 

By: /s/ Kuk Hyoun Hwang  
Name:  Kuk Hyoun Hwang  
Title: Chief Executive Officer  
Date: April 22, 2026  

 

2

 

FAQ

What executive change did OSR Holdings (OSRH) announce in this 8-K?

OSR Holdings appointed Yeiseok Kim as its new Chief Operating Officer, effective April 16, 2026. The Board approved this move on March 26, 2026, and his role is supported by an amended employment agreement reflecting increased annual compensation.

What is Yeiseok Kim’s background before becoming COO of OSR Holdings (OSRH)?

Before becoming COO, Yeiseok Kim served as a Senior Analyst at OSR Holdings Co., Ltd. from 2020 to 2025. He focused on cross-border healthcare investments and pharmaceutical licensing, building experience directly relevant to the company’s healthcare-related business activities.

What are Yeiseok Kim’s academic and professional qualifications at OSR Holdings (OSRH)?

Yeiseok Kim holds a BA in Environmental Science from Seoul National University and an MS in Medicine from Jeonbuk National University. He also obtained his Korean medical license in 2019, combining medical training with investment experience in healthcare and pharmaceuticals.

Are there any special arrangements behind Yeiseok Kim’s appointment at OSR Holdings (OSRH)?

The company reports there are no arrangements or understandings between Yeiseok Kim and any other person that led to his appointment as Chief Operating Officer. His selection appears to be based on his qualifications and prior work with the company’s subsidiary.

What employment changes accompany Yeiseok Kim’s new COO role at OSR Holdings (OSRH)?

OSR Holdings Co., Ltd. entered into an amended employment agreement with Yeiseok Kim in connection with his COO appointment. The agreement reflects his service as Chief Operating Officer of the company and includes an increase in his annual compensation compared with prior terms.

Filing Exhibits & Attachments

4 documents